Donanemab, sold under the brand name Kisunla, is a monoclonal antibody used for the treatment of Alzheimer's disease. Donanemab was developed by Eli Lilly and Company. From Wikipedia
Lumipulse test offers a less invasive, cost-effective alternative for detecting amyloid plaques in symptomatic adults 55 and older.
